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ABSTRACT 
Leptin is a substance that is released from adipose tissue and although it is 
primarily employed to modify body size, it also targets a number of other tissues, 
including the myocardium. Although plasma leptin concentrations may predict 
cardiovascular risk beyond conventional measurements, it is uncertain whether this may 
be explained by an independent effect on left ventricular mass (LVM) and geometry. 
Previous clinical studies evaluating the independent relationship between plasma leptin 
concentrations and LVM have been conducted in either small study samples (n=31-55), 
in severely obese participants only, in select subgroups (with insulin resistance) or in 
population samples with a relatively low mean body mass index (BMI). In the present 
dissertation I therefore assessed whether plasma leptin concentrations are associated 
with LVM and LV mean wall thickness independent of adiposity indices in 378 adults of 
African descent randomly recruited from a population sample with ~63% of people whom 
were either overweight or obese. LVM was determined using two-dimensional directed 
M-mode echocardiography and indexed to height2.7 (LVMI). ~28% of the sample had LV 
hypertrophy. Marked differences in plasma leptin concentrations were noted between 
men and women. Thus, multivariate regression analysis was employed to identify 
independent relations between plasma leptin concentrations and either LVMI or LV 
mean wall thickness in sex-specific groups. 
Before adjustments for potential confounders, plasma leptin concentrations were 
associated with LVMI in both women (r=0.25, p<0.0001) and in men (r=0.20, p=0.017) 
as well as with LV mean wall thickness in both women (r=0.22, p<0.001) and in men 
(r=0.27, p=0.002). Moreover, participants with LV hypertrophy defined as an LVM index 
of >51 g/m2 had markedly greater plasma leptin concentrations than those participants 
without LV hypertrophy. However, plasma leptin concentrations were also associated 
with age, conventional systolic blood pressure and with adiposity indices (p<0.0001), 
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factors that had robust relationships with LVMI and LV mean wall thickness. In 
multivariate regression models with plasma leptin concentrations, adiposity indices, age, 
systolic blood pressure and a number of alternative potential confounders in the same 
regression model, although adiposity indices were strong independent predictors of both 
LVMI and LV mean wall thickness in both women and men (p<0.002-p<0.0001), plasma 
leptin concentrations were not independently related to either LVMI (p=0.32-0.96), or LV 
mean wall thickness (p=0.33-0.81). In conclusion, plasma leptin concentrations, although 
associated with, are not independent predictors of LVMI beyond adiposity indices and 
other related factors in a population sample with a high prevalence of excess adiposity. 
Therefore, plasma leptin concentrations are unlikely to predict cardiovascular risk 
beyond conventional risk measurements because of an impact on LVM. 
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PREFACE 
 Epidemiological surveys suggest that obesity is likely to become one of the major 
public health problems of the present century. Of the complications of obesity, 
cardiovascular disease, including strokes, myocardial infarction and heart failure, play a 
major role in obesity-induced morbidity and mortality. Although it is well accepted that 
obesity contributes toward cardiovascular disease by promoting the development of 
conventional cardiovascular risk factors including hypertension, dyslipidaemia and type II 
diabetes mellitus, there is increasing evidence to suggest that excessive adipose tissue 
may promote adverse effects on the cardiovascular system, which are not necessarily 
accounted for by conventional cardiovascular risk factors. One such effect is through an 
impact on left ventricular hypertrophy, a cardiovascular change that is a strong and 
independent predictor of cardiovascular morbidity and mortality. 
 Although there are a number of hypotheses that may explain obesity-induced 
effects on left ventricular growth, more recently there has been a suggestion that 
substances released from adipose tissue, such as the adipokine, leptin, may promote 
cardiac hypertrophy. In this regard, in the hopes of identifying obese people at risk of 
excessive cardiovascular target organ changes, a few studies have been performed to 
assess the independent relations between plasma leptin concentrations and left 
ventricular mass and geometry. The outcomes of these studies have been inconsistent 
and difficult to interpret due to the small number of participants studied, the extreme 
nature of the degree of obesity studied, or in larger studies conducted at a population 
level, the relatively low prevalence of obesity noted in the populations sampled. Thus, in 
the present dissertation, I assessed the independent relationship between plasma leptin 
concentrations and left ventricular mass and wall thickness in a randomly selected 
sample (n=378) of a community with a high prevalence of excess adiposity (~63%). 
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 The present dissertation is presented as a series of chapters that guide the 
reader first through the background and purpose of the study (Chapter 1), then through 
the methods employed (Chapter 2), subsequently through the results of the present 
study (Chapter 3) and finally through a summary of the data, a discussion of the data in 
the context of previous studies, and the strengths and limitations of the present study 
(Chapter 4). In chapter 1, the present evidence to suggest that cardiac hypertrophy is a 
predictor of cardiovascular risk beyond alternative cardiovascular risk factors is 
reviewed. Thereafter, our present understanding of the role of obesity as a determinant 
of cardiac hypertrophy and the potential mechanisms thereof is reviewed. 
